Journal article
Current therapy for hypoplastic left heart syndrome and related single ventricle lesions
RG Ohye, D Schranz, Y D'Udekem
Circulation | LIPPINCOTT WILLIAMS & WILKINS | Published : 2016
Abstract
Universally fatal only 4 decades ago, the progress in the 3-stage palliation of hypoplastic left heart syndrome and related single right ventricular lesions has drastically improved the outlook for these patients. Although the stage II operation (hemi-Fontan or bidirectional Glenn) and stage III Fontan procedure have evolved into relatively low-risk operations, the stage I Norwood procedure remains one of the highest-risk and costliest common operations performed in congenital heart surgery. Yet, despite this fact, experienced centers now report hospital survivals of >90% for the Norwood procedure. This traditional 3-stage surgical palliation has seen several innovations in the past decade a..
View full abstractGrants
Awarded by National Heart, Lung, and Blood Institute
Funding Acknowledgements
Dr Ohye: The Single Ventricle Reconstruction trial was supported by grants (HL068269, HL068270, HL068279, HL068281, HL068285, HL068288, HL068290, HL068292, and HL085057) from the National Heart, Lung, and Blood Institute (NHLBI). This work is solely the responsibility of the authors and does not necessarily represent the official views of NHLBI or NIH.